Tessa L. Weir
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Tessa L. Weir has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Sarah Jean Glastras
Faculty of Medicine and Health University of Sydney Sydney New South Wales Australia
3 shared publications Deborah Randall
Reproduction and Perinatal Centre – Northern Precinct, Faculty of Medicine and Health, the University of Sydney Sydney New South Wales Australia
2 shared publications- Ibinabo Ibiebele
Reproduction and Perinatal Centre – Northern Precinct, Faculty of Medicine and Health, the University of Sydney Sydney New South Wales Australia
2 shared publications Monica Majumder
Department of Endocrinology Royal North Shore Hospital St Leonards New South Wales Australia
2 shared publicationsTanya Nippita
Reproduction and Perinatal Centre – Northern Precinct, Faculty of Medicine and Health, the University of Sydney Sydney New South Wales Australia
2 shared publicationsFelicity Gallimore
Reproduction and Perinatal Centre Northern Precinct, Faculty of Medicine and Health The University of Sydney Sydney New South Wales Australia
1 shared publication
Latest Publications
- Open Access
- 28 July 2026
- Published by Wiley in Australian and New Zealand Journal of Obstetrics and Gynaecology
- Vol. 66 (4) , e70164
Outcomes for Women With Diabetes at Late Preterm Gestation Who Received Antenatal Corticosteroids: A Population‐Based Cohort Study
Background: The use of antenatal corticosteroids appears to be increasing despite limited and conflicting evidence about its efficacy among women with diabetes in pregnancy. Aim: To separately assess the effects of maternal diabetes and the effects of antenatal corticosteroid administration prior to late preterm birth on adverse maternal and neonatal outcomes. Materials and Methods: Cohort study of women who gave birth ≥ 35 weeks gestation between September 2016 and March 2021 in two local health districts in New South Wales, Australia. Women were grouped into one of the following: (1) diabetes and received corticosteroids, (2) diabetes and no corticosteroids, (3) no diabetes and received corticosteroids. Modified Poisson regression was used to estimate adjusted relative risks (aRR). Results: A total of 5 067 women were included (Group 1 = 205, Group 2 = 4 028, Group 3 = 834). Women who received corticosteroids were characterised by higher proportions of hypertension, hospital‐based medical antenatal care, multiple births and caesarean section. There were no differences in maternal and neonatal outcomes for women who had diabetes and received corticosteroids compared to those who had diabetes and did not receive corticosteroids. Women with diabetes who received corticosteroids had a higher risk of infants with neonatal hypoglycaemia (aRR 1.61, 95% CI 1.28–2.02) and admission to nursery or intensive care unit (aRR 1.18, 95% CI 1.02–1.38), compared to women without diabetes who received corticosteroids. Conclusions: There is limited evidence of benefit for the use of antenatal corticosteroids in late preterm gestations, regardless of diabetes status. Further studies are required to identify potential longer‐term benefits or harms.
- 28 July 2026
- Published by Wiley in Australian and New Zealand Journal of Obstetrics and Gynaecology
- Vol. 66 (4) , e70164
Open AccessOutcomes for Women With Diabetes at Late Preterm Gestation Who Received Antenatal Corticosteroids: A Population‐Based Cohort Study
Background: The use of antenatal corticosteroids appears to be increasing despite limited and conflicting evidence about its efficacy among women with diabetes in pregnancy. Aim: To separately assess the effects of maternal diabetes and the effects of antenatal corticosteroid administration prior to late preterm birth on adverse maternal and neonatal outcomes. Materials and Methods: Cohort study of women who gave birth ≥ 35 weeks gestation between September 2016 and March 2021 in two local health districts in New South Wales, Australia. Women were grouped into one of the following: (1) diabetes and received corticosteroids, (2) diabetes and no corticosteroids, (3) no diabetes and received corticosteroids. Modified Poisson regression was used to estimate adjusted relative risks (aRR). Results: A total of 5 067 women were included (Group 1 = 205, Group 2 = 4 028, Group 3 = 834). Women who received corticosteroids were characterised by higher proportions of hypertension, hospital‐based medical antenatal care, multiple births and caesarean section. There were no differences in maternal and neonatal outcomes for women who had diabetes and received corticosteroids compared to those who had diabetes and did not receive corticosteroids. Women with diabetes who received corticosteroids had a higher risk of infants with neonatal hypoglycaemia (aRR 1.61, 95% CI 1.28–2.02) and admission to nursery or intensive care unit (aRR 1.18, 95% CI 1.02–1.38), compared to women without diabetes who received corticosteroids. Conclusions: There is limited evidence of benefit for the use of antenatal corticosteroids in late preterm gestations, regardless of diabetes status. Further studies are required to identify potential longer‐term benefits or harms.
- Open Access
- 24 March 2026
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
Bariatric Surgery, Gestational Diabetes and Perinatal Outcomes: A Population‐Based Study
Objective: To examine the independent and combined associations of metabolic and bariatric surgery (MBS) and gestational diabetes mellitus (GDM) with adverse maternal and neonatal outcomes. Design: Population‐based retrospective cohort study. Setting: New South Wales (NSW), Australia. Population: Four hundred twenty‐nine thousand five hundred seventy‐six singleton births from 2016 to 2020 in NSW, including 3001 women with a history of MBS. Methods: Linked perinatal and hospital data were used to classify women into four groups: no MBS/no GDM, MBS/no GDM, GDM/no MBS, and GDM/MBS. Multivariable logistic regression was used to examine associations with adverse outcomes, adjusting for maternal age, BMI, parity, smoking, country of birth, and gestational age. Main Outcome Measures: Neonatal and maternal outcomes including preterm birth, (large‐for‐gestational‐age) LGA, small‐for‐gestational‐age (SGA), neonatal hypoglycaemia, preeclampsia and postpartum haemorrhage. Results: Women with both GDM and prior MBS had the highest odds of adverse outcomes. Compared to women without GDM or surgery, this group had increased odds of LGA (aOR 1.42, 95% CI 1.22–1.65), preterm birth (aOR 1.93, 95% CI 1.52–2.42), and neonatal hypoglycaemia (aOR 4.98, 95% CI 4.22–5.84). Preeclampsia risk was modestly increased across all groups but attenuated after BMI adjustment. Postpartum haemorrhage was reduced in women with prior surgery (aOR 0.81, 95% CI 0.72–0.92), while induction of labour was more likely in all exposure groups. Conclusions: gestational diabetes mellitus (GDM) and prior MBS confer independent and combined risks for adverse perinatal outcomes. These findings support the need for personalised antenatal care strategies in this high‐risk population.
- 24 March 2026
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
Open AccessBariatric Surgery, Gestational Diabetes and Perinatal Outcomes: A Population‐Based Study
Objective: To examine the independent and combined associations of metabolic and bariatric surgery (MBS) and gestational diabetes mellitus (GDM) with adverse maternal and neonatal outcomes. Design: Population‐based retrospective cohort study. Setting: New South Wales (NSW), Australia. Population: Four hundred twenty‐nine thousand five hundred seventy‐six singleton births from 2016 to 2020 in NSW, including 3001 women with a history of MBS. Methods: Linked perinatal and hospital data were used to classify women into four groups: no MBS/no GDM, MBS/no GDM, GDM/no MBS, and GDM/MBS. Multivariable logistic regression was used to examine associations with adverse outcomes, adjusting for maternal age, BMI, parity, smoking, country of birth, and gestational age. Main Outcome Measures: Neonatal and maternal outcomes including preterm birth, (large‐for‐gestational‐age) LGA, small‐for‐gestational‐age (SGA), neonatal hypoglycaemia, preeclampsia and postpartum haemorrhage. Results: Women with both GDM and prior MBS had the highest odds of adverse outcomes. Compared to women without GDM or surgery, this group had increased odds of LGA (aOR 1.42, 95% CI 1.22–1.65), preterm birth (aOR 1.93, 95% CI 1.52–2.42), and neonatal hypoglycaemia (aOR 4.98, 95% CI 4.22–5.84). Preeclampsia risk was modestly increased across all groups but attenuated after BMI adjustment. Postpartum haemorrhage was reduced in women with prior surgery (aOR 0.81, 95% CI 0.72–0.92), while induction of labour was more likely in all exposure groups. Conclusions: gestational diabetes mellitus (GDM) and prior MBS confer independent and combined risks for adverse perinatal outcomes. These findings support the need for personalised antenatal care strategies in this high‐risk population.
- Open Access
- 27 November 2025
- Published by Wiley in Diabetic Medicine
- Vol. 43 (2)
Assessing the independent and combined impact of obesity and gestational diabetes mellitus on adverse maternal outcomes: A systematic review and meta‐analysis
Aims: To evaluate the impact of obesity, with or without gestational diabetes mellitus (GDM), on adverse maternal outcomes and determine whether the combination of obesity and GDM confers a greater risk compared to obesity alone. Methods: We systematically searched MEDLINE, EMBASE, Scopus, CINAHL and the WoS Core Collection, identifying 19 studies. Pooled estimates (odds ratios, OR and mean differences, MD) with 95% confidence intervals (CI) were calculated using random effects models. Results: Obesity alone significantly increased the risk of caesarean section (OR 2.63, 95% CI 1.40–4.94), pre‐eclampsia (OR 3.09, 95% CI 2.35–4.07), induction of labour (OR 1.73, 95% CI 1.58–1.90) and postpartum haemorrhage (OR 1.35, 95% CI 1.01–1.81) compared to normal‐weight, non‐GDM women. GDM alone also increased the risk of caesarean section (OR 1.66, 95% CI 1.28–2.15) and pre‐eclampsia (OR 1.57, 95% CI 1.21–2.04), though to a lesser extent. Combined, obesity and GDM markedly elevated risks, with a four‐fold increase in caesarean section (OR 4.26, 95% CI 1.57–11.53) and pre‐eclampsia (OR 4.07, 95% CI 2.90–5.71), and a sixfold increase for induction of labour (OR 6.44, 95% CI 1.25–24.63). Comparatively, obesity alone conferred a higher risk for caesarean section and pre‐eclampsia than GDM alone (OR 1.45, 95% CI 1.03–2.03 and OR 2.15, 95% CI 1.50–3.09, respectively). No significant differences were observed for instrumental delivery rates. Conclusions: Obesity contributes significantly to adverse maternal outcomes, conferring a greater risk for caesarean section and pre‐eclampsia than GDM alone. The combination of obesity and GDM amplifies these risks, underscoring the need to prioritise obesity management as a distinct focus in pregnancy care.
- 27 November 2025
- Published by Wiley in Diabetic Medicine
- Vol. 43 (2)
Open AccessAssessing the independent and combined impact of obesity and gestational diabetes mellitus on adverse maternal outcomes: A systematic review and meta‐analysis
Aims: To evaluate the impact of obesity, with or without gestational diabetes mellitus (GDM), on adverse maternal outcomes and determine whether the combination of obesity and GDM confers a greater risk compared to obesity alone. Methods: We systematically searched MEDLINE, EMBASE, Scopus, CINAHL and the WoS Core Collection, identifying 19 studies. Pooled estimates (odds ratios, OR and mean differences, MD) with 95% confidence intervals (CI) were calculated using random effects models. Results: Obesity alone significantly increased the risk of caesarean section (OR 2.63, 95% CI 1.40–4.94), pre‐eclampsia (OR 3.09, 95% CI 2.35–4.07), induction of labour (OR 1.73, 95% CI 1.58–1.90) and postpartum haemorrhage (OR 1.35, 95% CI 1.01–1.81) compared to normal‐weight, non‐GDM women. GDM alone also increased the risk of caesarean section (OR 1.66, 95% CI 1.28–2.15) and pre‐eclampsia (OR 1.57, 95% CI 1.21–2.04), though to a lesser extent. Combined, obesity and GDM markedly elevated risks, with a four‐fold increase in caesarean section (OR 4.26, 95% CI 1.57–11.53) and pre‐eclampsia (OR 4.07, 95% CI 2.90–5.71), and a sixfold increase for induction of labour (OR 6.44, 95% CI 1.25–24.63). Comparatively, obesity alone conferred a higher risk for caesarean section and pre‐eclampsia than GDM alone (OR 1.45, 95% CI 1.03–2.03 and OR 2.15, 95% CI 1.50–3.09, respectively). No significant differences were observed for instrumental delivery rates. Conclusions: Obesity contributes significantly to adverse maternal outcomes, conferring a greater risk for caesarean section and pre‐eclampsia than GDM alone. The combination of obesity and GDM amplifies these risks, underscoring the need to prioritise obesity management as a distinct focus in pregnancy care.
- Top Cited PapersOpen Access
- 28 April 2024
- Published by Wiley in Obesity Reviews
- Vol. 25 (7) , e13747
A systematic review of the effects of maternal obesity on neonatal outcomes in women with gestational diabetes
Summary: Maternal obesity and gestational diabetes mellitus (GDM) prevalence are increasing, with both conditions associated with adverse neonatal outcomes. This review aimed to determine the risk of adverse outcomes in women with obesity and GDM, compared with women with obesity alone. A systematic search identified 28 eligible articles. Meta‐analysis was conducted using a random effects model, to generate pooled estimates (odds ratios, OR, or mean difference, MD). Compared with normal‐weight controls, women with obesity had increased risks of large for gestational age (LGA, OR 1.98, 95% CI: 1.56, 2.52) and macrosomia (OR 2.93, 95% CI: 1.71, 5.03); the latter's risk almost double in women with obesity than GDM. Birth weight (MD 113 g, 95% CI: 69, 156) and shoulder dystocia (OR 1.23, 95% CI: 0.85, 1.78) risk was also higher. GDM significantly amplified neonatal risk in women with obesity, with a three‐ to four‐fold risk of LGA (OR 3.22, 95% CI: 2.17, 4.79) and macrosomia (OR 3.71, 95% CI: 2.76, 4.98), as well as higher birth weights (MD 176 g, 95% CI: 89, 263), preterm delivery (OR 1.49, 95% CI: 1.25, 1.77), and shoulder dystocia (OR 1.99, 95% CI: 1.31, 3.03), when compared with normal‐weight controls. Our findings demonstrate that maternal obesity increases serious neonatal adverse risk, magnified by the presence of GDM. Effective strategies are needed to safeguard against neonatal complications associated with maternal obesity, regardless of GDM status.
- 28 April 2024
- Published by Wiley in Obesity Reviews
- Vol. 25 (7) , e13747
Top Cited PapersOpen AccessA systematic review of the effects of maternal obesity on neonatal outcomes in women with gestational diabetes
Summary: Maternal obesity and gestational diabetes mellitus (GDM) prevalence are increasing, with both conditions associated with adverse neonatal outcomes. This review aimed to determine the risk of adverse outcomes in women with obesity and GDM, compared with women with obesity alone. A systematic search identified 28 eligible articles. Meta‐analysis was conducted using a random effects model, to generate pooled estimates (odds ratios, OR, or mean difference, MD). Compared with normal‐weight controls, women with obesity had increased risks of large for gestational age (LGA, OR 1.98, 95% CI: 1.56, 2.52) and macrosomia (OR 2.93, 95% CI: 1.71, 5.03); the latter's risk almost double in women with obesity than GDM. Birth weight (MD 113 g, 95% CI: 69, 156) and shoulder dystocia (OR 1.23, 95% CI: 0.85, 1.78) risk was also higher. GDM significantly amplified neonatal risk in women with obesity, with a three‐ to four‐fold risk of LGA (OR 3.22, 95% CI: 2.17, 4.79) and macrosomia (OR 3.71, 95% CI: 2.76, 4.98), as well as higher birth weights (MD 176 g, 95% CI: 89, 263), preterm delivery (OR 1.49, 95% CI: 1.25, 1.77), and shoulder dystocia (OR 1.99, 95% CI: 1.31, 3.03), when compared with normal‐weight controls. Our findings demonstrate that maternal obesity increases serious neonatal adverse risk, magnified by the presence of GDM. Effective strategies are needed to safeguard against neonatal complications associated with maternal obesity, regardless of GDM status.